Johnson & Johnson Ordered to Pay $181 Million in Legal Fees in Arkansas Risperdal Suit

An Arkansas judge says Johnson & Johnson must pay $181 million in fees to attorneys who successfully argued that the pharmaceutical company committed Medicaid fraud in the marketing of its antipsychotic drug Risperdal. Pulaski County Judge Tim Fox ruled Thursday that Arkansas taxpayers should not foot the bill in the lawsuit filed by the state’s attorney general. Last year, a jury found that Johnson & Johnson, through its Janssen Pharmaceuticals subsidiary, had committed Medicaid fraud and violated the state’s deceptive trade practices act.